The prognostic data involving the pooled hazard ratio (HR) were insufficient and not available, as only three studies reporting showed that p16INK4A and p14ARF gene promoter methylation were not significantly correlated with the prognosis of RCC in OS or DFS [22, 23, 25]. This evidence concerns the gene CDKN2A and renal cell carcinoma.